Skip to main content
TipRanks
Go Ultimate75% OFF

OncoTherapy Science (30O) Q2 2026 Earnings Report

0 Followers

DE:30O Q2 2026 EPS Results

Actual EPS
EUR 0.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.00

DE:30O Q2 2026 Revenue Results

Actual Revenue
EUR 929.18K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
11/06/2026
Time
TBA
Conference Call
Friday, November 6, 2026
DE:30O Upcoming Earnings

OncoTherapy Science's next earnings date is estimated for January 29, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:30O Earnings History

DE:30O earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 29, 20272026 (Q3)―--0.01――
Nov 06, 20262026 (Q2)―-0.0007.89% (+0.00)
Aug 07, 20262026 (Q1)―-0.00-0.0136.28% (+0.00)
Feb 06, 20262025 (Q3)―-0.000-5.00% (-0.00)
Feb 07, 20252024 (Q3)―-0.00-0.0152.38% (+0.00)
Aug 02, 20242025 (Q1)―-0.01-0.0134.67% (+0.00)
Aug 04, 20232024 (Q1)―-――
May 12, 20232023 (Q4)―-――
Feb 03, 20232023 (Q3)―-――
Aug 05, 20222023 (Q1)―-0.01-0.0252.00% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed